Filter by: patients
Home > Community Treatment Reports and Side Effects > Jarro-Dophilus EPS Treatment Report
What is Jarro-Dophilus EPS?

Jarro-Dophilus EPS™, a brand name probiotic product, Stable-Dophilus due to its stability at room temperature and enteric coating with eight different strains of probiotic bacteria delivered directly into small intestines.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Increase effect of another treatment 1 1 Efficacy_moderate
intestinal health 1 1 Efficacy_major
General health 1 1 Efficacy_moderate
Improve swallowing 1 1 Efficacy_moderate
Yeast Infection (candida) 1 1 Efficacy_moderate

See all 2 patients currently taking Jarro-Dophilus EPS

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 1
None
 1

Commonly reported side effects, conditions, and hospitalizations associated with Jarro-Dophilus EPS

Loose stools 1

Reported Dosages

  1 other daily 2 other daily
  1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Jarro-Dophilus EPS (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 1   Doctor's advice: 100%
Side effects too severe 1   Side effects too severe: 100%

See all 1 patient who’ve stopped taking Jarro-Dophilus EPS

Reported Duration See details about how long patients take this treatment ▼

Stopped Taking Jarro-Dophilus EPS

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Jarro-Dophilus EPS

Always
 0 0%
Usually
 2 100%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Jarro-Dophilus EPS

Very
 1 50%
Somewhat
 0 0%
A little
 0 0%
Not at all
 1 50%

Cost

Paid out of pocket

Cost of Jarro-Dophilus EPS

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 2 100%

Report created on May 26, 2012.